Scinai Immunotherapeutics (SCNI) Other Non-Current Liabilities (2016 - 2025)

Scinai Immunotherapeutics has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $3000.0 for Q2 2025.

• In Q2 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $3000.0; the TTM figure through Jun 2025 stood at $3000.0 (changed 0.0% YoY), while the FY2024 annual figure was $3000.0, down 96.88% from the prior year.
• Other Non-Current Liabilities came in at $3000.0 for Q2 2025 at Scinai Immunotherapeutics, roughly flat from $3000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.3 million in Q4 2022 to a low of $3000.0 in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $980000.0, with a median of $243500.0 recorded in 2021.
• Year-over-year, Other Non-Current Liabilities slumped 99.67% in 2024 and changed 0.0% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $176000.0 in 2021, then jumped by 2927.84% to $5.3 million in 2022, then tumbled by 98.2% to $96000.0 in 2023, then plunged by 96.88% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $3000.0 in Q2 2025, $3000.0 in Q4 2024, and $3000.0 in Q3 2024.